This inventor holds 1 USPTO granted patent. Top assignee: Imperial Innovations Limited. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: David Michael Vigushin: Innovator in HDAC Inhibition
Introduction
David Michael Vigushin is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit HDAC enzyme activity. His work is crucial for advancing treatments for various medical conditions.
Latest Patents
David holds a patent for "Compounds and uses thereof." This patent describes a compound of formula (I), wherein R, R, R, X to X, a, b, and c have specific meanings as detailed in the description. These compounds are particularly useful as prodrugs of inhibitors of HDAC enzyme activity, which is essential in treating conditions that require such inhibition.
Career Highlights
David is associated with Imperial Innovations Limited, where he continues to work on innovative solutions in the field of biochemistry. His expertise and dedication have positioned him as a key figure in his area of research.
Collaborations
David collaborates with talented individuals such as Eric Ofori Aboagye and Wendy Vigushin, who serves as his legal representative. These collaborations enhance the quality and impact of his work.
Conclusion
David Michael Vigushin's contributions to the field of HDAC inhibition through his innovative compounds are noteworthy. His work not only advances scientific understanding but also holds promise for future medical applications.